Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-03-20 16:12:02
Reporting Period:
Filing Date:
Accepted Time:
2014-03-20 16:12:02
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008310 D Peter Meldrum 320 Wakara Way
Salt Lake City UT 84108
President & C.e.o. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-19 55,000 $30.12 81,084 No 4 M Direct
Common Stock Disposition 2014-03-19 55,000 $37.00 26,084 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-03-19 55,000 $0.00 55,000 $30.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
107,654 2019-02-18 No 4 M Direct
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.